Elevance Health Files 8-K

Ticker: ELV · Form: 8-K · Filed: 2024-10-31T00:00:00.000Z

Sentiment: neutral

Topics: filing, financials, sec

TL;DR

Elevance Health filed an 8-K on Oct 31st, mostly financial docs.

AI Summary

Elevance Health, Inc. filed an 8-K on October 31, 2024, reporting an event that occurred on October 22, 2024. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.

Why It Matters

This filing indicates Elevance Health is providing updated financial information or exhibits to the SEC, which could be relevant for investors assessing the company's financial health.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial statements and exhibits, not indicating any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What specific financial statements or exhibits are being filed with this 8-K?

The provided text states the filing includes 'Financial Statements and Exhibits' but does not list the specific documents.

What was the nature of the event reported on October 22, 2024?

The filing indicates an event occurred on October 22, 2024, but the details are not specified in the provided excerpt, which focuses on the filing's administrative information.

What is Elevance Health's principal executive office address?

The principal executive offices are located at 220 Virginia Avenue, Indianapolis, IN 46204.

What is Elevance Health's telephone number?

The registrant's telephone number is (833) 401-1577.

Has Elevance Health previously operated under different names?

Yes, Elevance Health was formerly known as Anthem, Inc. (name change effective December 2, 2014), WELLPOINT, INC (name change effective January 5, 2010), and WELLPOINT INC (name change effective November 30, 2004).

From the Filing

0001193125-24-248691.txt : 20241031 0001193125-24-248691.hdr.sgml : 20241031 20241031161558 ACCESSION NUMBER: 0001193125-24-248691 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 24 CONFORMED PERIOD OF REPORT: 20241022 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241031 DATE AS OF CHANGE: 20241031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 241415437 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 d888716d8k.htm 8-K 8-K false 0001156039 0001156039 2024-10-22 2024-10-22     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2024 ( October 22, 2024 )     Elevance Health, Inc. (Exact name of registrant as specified in its charter)       Indiana   001-16751   35-2145715 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 220 Virginia Avenue Indianapolis , IN 46204 (Address of principal executive offices) (Zip Code) (833) 401-1577 (Registrant’s telephone number, including area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see  General Instruction A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock   ELV   NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01 Other Events. The Notes Offering On October 31, 2024, Elevance Health, Inc. (the “Company”) closed its sale of $350 million aggregate principal amount of its 4.500% Notes due 2026 (the “2026 Notes”), $750 million aggregate principal amount of its 4.750% Notes due 2030 (the “2030 Notes”), $750 million aggregate principal amount of its 4.950% Notes due 2031 (the “2031 Notes”), $1,200 million aggregate principal amount of its 5.200% Notes due 203

View on Read The Filing